Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)

References

• Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476–92
   PubMed Web of Science ®Google Scholar
• Gunderson LL. Indications for and results of combined modality treatment of colorectal cancer. Acta Oncol 1999; 38: 7–21
   PubMed Web of Science ®Google Scholar
• Glimelius B. Chemoradiotherapy for rectal cancer – is there an optimal combination?. Ann Oncol 2001; 12: 1039–45
   PubMed Web of Science ®Google Scholar
• Frykholm GJ, Påhlman L, Glimelius B. Combined chemo-radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001; 50: 427–34
   PubMed Web of Science ®Google Scholar
• O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502–7
   PubMed Web of Science ®Google Scholar
• Sadahiro S, Suzuki T, Kameya T, Iwase H, Tajima T, Makuuchi H. A pharmacological study of the weekday-on/weekday-off oral UFT schedule in colorectal cancer patients. Cancer Chemother Pharmacol 2001; 47: 447–50
   Web of Science ®Google Scholar
• Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, et al. Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000; 46: 883–8
   PubMed Web of Science ®Google Scholar
• Glimelius B, Isacsson U, Jung B, Påhlman L. Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys 1997; 37: 281–7
   PubMed Web of Science ®Google Scholar
• Hartley A, Ho KF, McConkey C, Geh JI. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials. Br J Radiol 2005; 78: 934–8
   PubMed Web of Science ®Google Scholar
• Pfeiffer P. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial. Acta Oncol 2005; 44: 224–9
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. New Engl J Med 2006; 355: 1114–23
   PubMed Web of Science ®Google Scholar
• Gerard J-P, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620–5
   PubMed Web of Science ®Google Scholar
• Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976–84
   PubMed Web of Science ®Google Scholar
• Reerink O, Mulder NH, Szabo BG, Sluiter WJ, Wiggers T, Bongaerts AH, et al. Developments in treatment of primary irresectable rectal cancer. Colorectal Dis 2004; 6: 406–17
   PubMedGoogle Scholar
• Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on down-staging and the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396–402
   PubMed Web of Science ®Google Scholar
• Pfeiffer P, Baatrup G, Jensen HA, Kronborg O. Ny behandlingsstrategi for patienter med primaer, ikkeresektabel rectumcancer. Ugeskr Laeger 2006; 168: 1857–60
   PubMedGoogle Scholar
• Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097–105
   PubMed Web of Science ®Google Scholar
• Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The LYON R96-02 randomized trial. J Clin Oncol 2004; 22: 2404–9
   PubMed Web of Science ®Google Scholar
• Jacobsen A, Mortensen JP, Bisgaard C, Lindebjerg J, Hansen JW, Rafaelsen SR. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Int J Radiat Oncol Biol Phys 2006; 64: 461–5
   PubMed Web of Science ®Google Scholar
• Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3605–16
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Hoff PM, Harper P, Bukowski RM, Cunningham D, Dufour P, et al. Oral capecitabine vs intravenous 5- fluorouracil and leucovorin; integrated efficacy data and novel analyses from two large, randomized, phase III trials. Br J Cancer 2004; 90: 1190–7
   PubMed Web of Science ®Google Scholar
• Klautke G, Fietkau R. Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: A review. Int J Colorectal Dis 2007; 22: 457–65
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Grainger J, Harrison M, Ostler P, Makris A. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: Should we be more cautious?. Br J Cancer 2006; 94: 363–71
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10: 1319–28
   PubMed Web of Science ®Google Scholar
• Glimelius B. Rectal cancer irradiation. Long course, short course or something else? Editorial. Acta Oncol 2006; 45: 1013–7
   PubMed Web of Science ®Google Scholar